Norditropin
Product Images NDC 54868-6146

Product Visual Gallery

This gallery contains 63 technical images submitted to the FDA as part of the official labeling for Norditropin (NDC 54868-6146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norditropin Nordiflex 5 mg/1.5 mL Prefilled Pen (A9fdc442 825b 4e01 91e5 A2c527509e89 01)

An instructional diagram of the NovoFine needle components and the Norditropin pen device. The illustration labels parts including the pen cap, threaded cap, cartridge with residual scale window, dosage selector, push button, and the needle parts: outer needle cap, inner needle cap, needle, and protective tab. The dosage indicator window is also shown on the pen.*

FDA Label Image

A (Pulling off the pen cap)

Instructional diagram showing a hand holding a Norditropin pen injector. The image demonstrates pushing the orange-colored injection button forward, indicated by a blue arrow, as part of the device's use instructions.*

FDA Label Image

B (Placing a new NovoFine disposable needle)

An instructional illustration showing a hand rotating the dial of a pen injector device, with a dosage window displaying a numeric scale. The image is part of a multi-step guide, indicated by a small letter B in the corner.*

FDA Label Image

C (Dialing the dose selector)

An instructional diagram illustrating how to adjust the dose on a Norditropin device. It shows a close-up of a hand turning the dose selector showing a dose display window with the value "0.0 mg" and "0.05" as incremental step on the dial.*

FDA Label Image

D (Tapping the cartridge)

An instructional illustration showing a close-up of a hand holding a Norditropin pen injector, with the thumb pressing a dial or button on the device. The image focuses on the dosage adjustment or administration step of the Norditropin pen.*

FDA Label Image

E (Pressing the push button)

An instructional illustration showing a hand holding a Norditropin injection pen with the thumb pressing a dial or button at the base, likely demonstrating the activation or dosage setting step for the injectable drug device.*

FDA Label Image

F (Setting the dose)

An instructional illustration showing a hand adjusting the dose on a Norditropin delivery pen by rotating the dose selector. The dial on the pen indicates medication dosage in milligrams.*

FDA Label Image

G (Giving the injection)

Illustration showing a hand holding a pen injector device, with an arrow indicating pressing down on the top of the device. The pen has a transparent dosage window and a blue upper section. The background is blue and white.*

FDA Label Image

Norditropin Nordiflex 10 mg/1.5 mL Prefilled Pen (A9fdc442 825b 4e01 91e5 A2c527509e89 09)

Illustrated diagram of the NovoFine® needle assembly for a Norditropin pen, showing labeled components including the pen cap, threaded cap, cartridge with residual scale, dosage indicator window, dosage selector, push button, outer and inner needle caps, needle, and protective tab.*

FDA Label Image

A (Pulling off the pen cap)

An instructional illustration showing a hand holding and twisting the cap of a Norditropin pen injector, with an arrow indicating the direction to turn the cap.*

FDA Label Image

B (Placing a new NovoFine disposable needle)

An instructional illustration showing a hand twisting or adjusting the cap or dial of a cylindrical device, likely a medication pen or injector. The background includes a scale marked with numbers 0 through 5, with an arrow indicating the direction to turn the cap or dial.*

FDA Label Image

C (Dialing the dosage selector)

An instructional illustration showing a hand adjusting the dose selector on a Norditropin injection pen. The dial displays dosing increments in milligrams, indicating how to set the correct dose before injection.*

FDA Label Image

D (Tapping the cartridge)

An instructional illustration showing a close-up of a hand gripping and adjusting a dosage dial on a Norditropin injectable pen device. The pen has a numbered scale visible, indicating dose settings.*

FDA Label Image

E (Pressing the push button)

Illustration showing a hand holding a Norditropin pen injector. The image focuses on preparing or administering the injection by highlighting the pen's dial mechanism and capped needle, with an arrow indicating a twisting or pressing motion at the pen's base.*

FDA Label Image

F (Setting the dose)

An instructional illustration showing a hand rotating the dose selector on a Norditropin pen device to set a dose of 0.1 mg. The image demonstrates the dose adjustment mechanism with the pen scale visible and a finger turning the dial clockwise.*

FDA Label Image

G (Giving the injection)

An instructional illustration showing a hand gripping an injectable pen device labeled Norditropin. The index finger is pressing down on the top button of the pen, indicated by a downward arrow, demonstrating how to activate or inject using the device.*

FDA Label Image

Norditropin Nordiflex 15 mg/1.5 mL Prefilled Pen (A9fdc442 825b 4e01 91e5 A2c527509e89 17)

An instructional diagram illustrating the components of the Norditropin pen injector and the NovoFine needle. Labeled parts of the pen include the pen cap, threaded cap, cartridge, residual scale with scale window, dosage selector, dosage indicator window, and push button. The needle components shown are the outer needle cap, inner needle cap, needle, and protective tab.*

FDA Label Image

A (Pulling off the pen cap)

An instructional illustration showing a hand holding a green and blue pen-like device labeled Norditropin. The hand is pulling the green part of the device in the direction indicated by a rightward pointing arrow, demonstrating a step in preparing or using the device.*

FDA Label Image

B (Placing a new NovoFine disposable needle)

An instructional illustration showing a hand turning the dial on a green Norditropin device. The image focuses on the dose adjustment step, indicated by a blue arrow pointing to the right to rotate the dial mechanism.*

FDA Label Image

C (Dialing the dosage selector)

An instructional diagram showing a hand adjusting the dose selector on a Norditropin pen injector. The visible dose display on the pen shows 0.0 to 0.15 mg, indicating dose adjustment functionality.*

FDA Label Image

D (Tapping the cartridge)

An instructional illustration showing a close-up of a hand adjusting the dosage dial on a green-filled syringe pen. The image highlights the finger turning the dosage setting, typically used for injectable medications like Norditropin.*

FDA Label Image

E (Pressing the push button)

An instructional illustration showing a hand holding a Norditropin pen injector, labeled with the letter E. The image demonstrates a step involving pressing or adjusting the bottom dial of the pen, indicated by an upward arrow, likely as part of the preparation or dosage setting process.*

FDA Label Image

F (Setting the dose)

An instructional illustration showing a hand adjusting a dial on a pen injector device, presumably for Norditropin. The dial displays dosage settings in milligrams, indicating dose selection or adjustment action.*

FDA Label Image

G (Giving the injection)

An instructional illustration showing a hand gripping a pen-style injection device with the thumb pressing down on the top button, likely demonstrating the activation or injection step of the device.*

FDA Label Image

Norditropin Nordiflex 30 mg/3 mL Prefilled Pen (A9fdc442 825b 4e01 91e5 A2c527509e89 25)

An illustration diagram showing parts of a Norditropin pen injector, including the pen cap, needle thread, cartridge with a residual scale window and residual scale, dosage indicator window, dosage selector, and push button. Also depicted are components of a NovoFine needle: outer needle cap, inner needle cap, needle, and protective tab.*

FDA Label Image

A (Pulling off the pen cap)

Instructional diagram showing a hand holding and twisting the cap of a pen device, with an arrow indicating the direction to turn the cap off or remove it. The illustration appears to demonstrate the first step in preparing the device for use.*

FDA Label Image

B (Placing a new NovoFine disposable needle.)

An instructional diagram showing a close-up of a hand holding a pen-like injector device, with the thumb pressing the plunger at the end of the device. The illustration focuses on the injection mechanism, likely related to the Norditropin product.*

FDA Label Image

C (Dialing the dosage selector)

An instructional illustration showing a hand adjusting a dose on a Norditropin injection pen. The image focuses on the dosage dial displaying numbers while demonstrating how to turn it for dose selection.*

FDA Label Image

D (Tapping the cartridge)

An instructional illustration showing a hand holding a syringe labeled with dose markers. The syringe is positioned vertically with a needle at the top, depicting the process of measuring or preparing an injection dose.*

FDA Label Image

E (Pressing the push button)

An instructional illustration showing a hand holding an injection pen, identified as Norditropin, with the thumb pressing the dose knob downward. The pen is depicted vertically with a visible dose window and cap at top, indicating the method to adjust or deliver medication dose.*

FDA Label Image

F (Setting the dose)

An instructional diagram showing a hand turning the dose selector on a Norditropin pen injector. The figure illustrates the technique to adjust the dosage by rotating the dial at the top of the pen.*

FDA Label Image

G (Giving the injection)

An instructional illustration showing a hand holding a Norditropin injection pen device vertically. The thumb is pressing down on the top of the device, indicating the step of administering the injection. The pen has dosage markings visible on its clear section near the bottom.*

FDA Label Image

Norditropin Flexpro (5 mg./1.5 mL (orange) Prefilled Pen)

An instructional diagram showing the components of the Norditropin FlexPro injection pen, including the pen cap, growth hormone scale, display window, pointer, dose selector, and dose button. The illustration also details parts of the needle assembly: outer needle cap, inner needle cap, needle, and paper tab.*

FDA Label Image

A (Pull off the pen cap.)

Instructional illustration showing how to twist and remove the cap from an injection pen device, indicated by fingers gripping the device and an arrow pointing to the direction of twisting. No proprietary name or other text is visible.*

FDA Label Image

B (Take a new disposable needle.)

Instructional illustration showing how to remove a cap from a pen-type device, likely for Norditropin, by pulling off the end cap and then twisting the pen mechanism, preparing it for use.*

FDA Label Image

C (Pull off the outer needle cap and the inner needle cap and throw them both away.)

Instructional illustration depicting how to remove and replace the needle cover on a syringe or injection pen, shown in two close-up steps with hands demonstrating the process. No specific product details are visible in the image.*

FDA Label Image

D (Turn the dose selector to select 0.025 mg.)

An instructional diagram showing a person holding and preparing a dose with a dose selector indicating 0.025 mg. The focus is on the interaction with the dosage dial, demonstrating dose setting and measurement for administration.*

FDA Label Image

E (Hold the pen and tap the top gently.)

An instructional illustration showing a hand holding a syringe pen device with a needle attached. The image focuses on the needle end of the pen with a finger pressing or operating it, indicating a step in medication injection or preparation.*

FDA Label Image

F (Press the dose button.)

An instructional illustration showing a hand holding a Norditropin delivery device. The image demonstrates the step of preparing the device by pulling the needle cover away from the syringe, indicated by an upward arrow. Inset shows a close-up of the needle tip with a protective cap to be removed before use.*

FDA Label Image

G (Select your dose.)

An instructional diagram showing a person adjusting the dose on a Norditropin device. The image highlights a dose setting of 0.3 mg being selected by turning the dose knob, illustrating the dosage adjustment process for the Norditropin injection pen.*

FDA Label Image

H (Inject your dose.)

An instructional illustration showing a hand holding a Norditropin injection pen with an instruction to wait for 6 seconds after injection. The image emphasizes pressing the pen tip and timing the injection duration with a stopwatch icon.*

FDA Label Image

I (Remove the needle from your skin.)

An instructional illustration showing the needle of a Norditropin pen being pulled upward away from the skin, indicated by a blue upward arrow. The image highlights part of the pen and a section of skin where an injection is being administered.*

FDA Label Image

Norditropin Flexpro 10 mg./1.5 mL (blue) Prefilled Pen (A9fdc442 825b 4e01 91e5 A2c527509e89 43)

An instructional diagram of the Norditropin FlexPro pen showing its components including the pen cap, growth hormone scale, display window, pointer, dose selector, dose button, and needle thread. Below the pen, an example needle is illustrated with outer needle cap, inner needle cap, needle, and paper tab labeled.*

FDA Label Image

A (Pull off the pen cap.)

An instructional illustration showing hands assembling or connecting two parts of a device, with an arrow indicating the direction to push or attach one part to the other. The image is related to the Norditropin product by Physicians Total Care, Inc.*

FDA Label Image

B (Take a new disposable needle.)

An instructional illustration showing hands preparing a pen-type injector: the top panel depicts insertion or removal of a transparent cap, and the bottom panel shows attaching or securing a needle to the pen device with an arrow indicating the direction of movement.*

FDA Label Image

C (Pull off the outer needle cap and the inner needle cap and throw them both away.)

An instructional illustration showing how to remove a protective cap from the needle of a Norditropin device. The top circle demonstrates pulling the cap straight off while the bottom circle shows the cap fully detached from the needle, both with directional arrows guiding the action.*

FDA Label Image

D (Turn the dose selector to select 0.05 mg.)

An instructional illustration showing how to select a 0.05 mg dose on a Norditropin pen device. The image highlights the dose window on the pen with a close-up of 0.05 mg selected, indicating the user's thumb adjusting the dial.*

FDA Label Image

E (Hold the pen and tap the top gently.)

An instructional illustration showing a finger pressing the top of a Norditropin injection pen to activate or prepare the device for use. The image highlights proper finger placement on the pen's dose button in a close-up circular frame.*

FDA Label Image

F (Press the dose button.)

An instructional illustration showing a hand holding a Norditropin pen device upright. An arrow points upward indicating a step in the injection process, accompanied by an inset close-up of the pen needle tip to guide proper attachment or use.*

FDA Label Image

G (Select your dose.)

An instructional diagram showing a hand adjusting the dose selector on a Norditropin pen injector to 0.3 mg, with a close-up inset highlighting the selected dose on the dosage window.*

FDA Label Image

H (Inject your dose.)

An instructional diagram showing a hand holding a Norditropin injection pen, with an arrow indicating pressing down the dose button. A close-up inset shows a magnified view of the dose window, and a stopwatch icon below indicates holding for six seconds during injection.*

FDA Label Image

I (Remove the needle from your skin.)

An instructional illustration showing an injection pen needle positioned above the skin with an upward pointing arrow, indicating the step to pull or withdraw the needle from the skin. The image is likely part of a user guide for Norditropin by Physicians Total Care, Inc.*

FDA Label Image

Norditropin Flexpro 15 mg/1.5 mL (green) Prefilled Pen (A9fdc442 825b 4e01 91e5 A2c527509e89 53)

An instructional illustration of the Norditropin FlexPro pen device, showing labeled parts including pen cap, growth hormone scale, display window, pointer, dose selector, and dose button. Additional labeled components of a needle example include outer needle cap, inner needle cap, needle, and paper tab.*

FDA Label Image

A (Pull off the pen cap.)

An instructional illustration showing the proper technique to remove or detach a green needle cover from a syringe pen. Two hands are depicted, with one hand holding the pen and the other pulling the needle cover away, indicated by a blue arrow pointing outward.*

FDA Label Image

B (Take a new disposable needle.)

An instructional illustration showing hands removing a cap from a pen device. The top panel indicates lifting the cap upward, while the bottom panel shows twisting the pen's green section, likely to prepare it for use. The diagram is part of a multi-step usage guide for the Norditropin device.*

FDA Label Image

C (Pull off the outer needle cap and the inner needle cap and throw them both away.)

An instructional illustration showing two steps of preparing an injection. The top part depicts a hand pulling back a plunger on a syringe or injector pen, while the bottom part shows a hand removing a protective cap from the needle. Both steps are indicated with directional arrows.*

FDA Label Image

D (Turn the dose selector to 0.1 mg..)

Illustration showing a close-up of a Norditropin injection pen with a dose selector set to 0.1 mg. The image demonstrates how to adjust the dose by turning the dial on the pen, highlighting the numeral and units for precise dosing.*

FDA Label Image

E (Hold the pen and tap the top gently.)

An instructional illustration showing a close-up of a hand tapping the top of a pen-like device with a needle cap. The image emphasizes the tapping action needed before injection, likely related to preparation or priming of a medication injecter device.*

FDA Label Image

F (Press the dose button.)

Illustration showing the proper handling of a Norditropin injection pen. It depicts a hand holding the pen with the thumb and forefinger, demonstrating the action of pulling the pen cap upward to remove it. An inset circle highlights the removal of the pen cap.*

FDA Label Image

G (Select your dose.)

An instructional illustration showing how to select a 0.3 mg dose on a Norditropin injection pen. A close-up inset highlights the dose display window on the pen, indicating "0.3 mg selected." A hand is adjusting the dose selector on the pen.*

FDA Label Image

H (Inject your dose.)

An instructional illustration showing a hand holding a Norditropin injection pen with an arrow pointing down to indicate proper use. The image includes icons depicting '0.30 mg' dosage and a 6-second timer, suggesting the duration for holding the pen during injection.*

FDA Label Image

I (Remove the needle from your skin.)

An instructional illustration showing a hypodermic needle attached to a pen device, positioned above skin with an arrow indicating the needle being directed downwards into the skin for injection.*

FDA Label Image

Norditropin Nordiflex 5 mg/1.5 mL (Package Label)

Label of Norditropin Nordiflex 5 mg/1.5 mL showing the product NDC 54868-6146, distributed by Physicians Total Care, Inc. in Tulsa, OK. The label includes lot number 0000 and an expiration date of 01/60. Manufacturer listed as Novo Nordisk A/S.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.